In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 35 for your search:
Drug:  celecoxib
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 19 to 70
Sponsor: Other
Protocol IDs: SNUBH-GS-HBP2, B-0712-052-006 (local IRB), NCT01111591
2.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000455008, MRC-STAMPEDE, EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476
3.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: tasmc-05-na-05160-ctil, NCT00295035
4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: TASMC-07-NA-132-CTIL, NCT00486460
5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-30801, CALGB-30801, NCT01041781
6.

Phase: Phase III
Type: Prevention
Status: Active
Age: 10 to 17
Sponsor: Pharmaceutical / Industry
Protocol IDs: A3191193, MDA-2006-0040, PFIZER-A3191193, N01-CN-05126-2, NCT00393016, NCT00585312
7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-80702, CALGB-SWOG-C80702, NCT01150045
8.

Phase: Phase II, Phase I
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 0596-2004, NCT00314262
9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: CLIN-003-09S, NCT00953849
10.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GCO # 06-0509, NCT00970502
11.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 100138, 10-C-0138, NCT01143545
12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 200806, NCT01425476
13.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-131, NCT01545141
14.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: COXAON-0509-047, GIA16125, NCT00215345
15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: K-EPIRU-0030-280-US, NCT00218205
16.

Phase: Phase II
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0305-20, NCT00198081
17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 3304C, NCT00250835
18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: VICC THO 0730, P30CA068485, VU-VICC-THO-0730, VU-VICC-IRB-070723, NCT00520845
19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 2 and over
Sponsor: Other
Protocol IDs: 1 U01 DC007946-01A2, U01DC007946, NIH grant U01DC007946-01A2, NCT00571701
20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CINJ-080811, 080811, 0220090006, NCT01220973
21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 2 to 30
Sponsor: Other
Protocol IDs: 2008-260, NCT00846430
22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 19 to 79
Sponsor: Other
Protocol IDs: T2207, NCT00931203
23.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 0078-09-EMC, NCT01067989
24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: 0082-09-EMC, NCT01175772
25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 4 to 21
Sponsor: Other
Protocol IDs: 2010-12, 2010-021792-81, NCT01285817
1   
New Search